Drp1 mediates high glucose-induced mitochondrial dysfunction and epithelial-mesenchymal transition in endometrial cancer cells

Exp Cell Res. 2020 Apr 1;389(1):111880. doi: 10.1016/j.yexcr.2020.111880. Epub 2020 Feb 1.

Abstract

This study aims to clarify the role and molecular mechanism of dynamin-related protein 1 (Drp1)-mediated mitochondrial homeostasis in high glucose (HG)-induced endometrial cancer (EC). Normal endometrium and tumor tissues of EC patients with normal and HG levels were collected, and Drp1 and p-Drp1 expression levels were detected by immunohistochemistry. Human EC cells were cultured with different glucose concentrations, and Drp1 and p-Drp1 expression levels were evaluated by Western blotting. Cell models of control and siDrp1 groups under normal and HG conditions were established, and subsequent functional experiments were conducted. Histology and in vitro experiments showed that the HG environment increased Drp1 activation, which could lead to mitochondrial dysfunction. Moreover, the imbalance of mitochondrial homeostasis mediated by Drp1 resulted in cell dysfunction, including altered glucose metabolism and increased epithelial-mesenchymal transition (EMT), migration and invasion. All these changes caused by HG could be partially alleviated by Drp1 knockdown. This study revealed that Drp1 was involved in the progression of EC associated with HG, and Drp1 might be a new potential therapeutic target for EC patients with diabetes.

Keywords: Drp1; Endometrial cancer; Epithelial-mesenchymal transition; High glucose; Mitochondria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood Glucose / physiology
  • Carcinoma, Endometrioid* / blood
  • Carcinoma, Endometrioid* / genetics
  • Carcinoma, Endometrioid* / pathology
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Dynamins / physiology*
  • Endometrial Neoplasms* / blood
  • Endometrial Neoplasms* / genetics
  • Endometrial Neoplasms* / pathology
  • Epithelial-Mesenchymal Transition* / drug effects
  • Epithelial-Mesenchymal Transition* / genetics
  • Female
  • Glucose / pharmacology*
  • Humans
  • Middle Aged
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Mitochondrial Dynamics* / drug effects
  • Mitochondrial Dynamics* / genetics
  • Mitochondrial Dynamics* / physiology
  • Tumor Cells, Cultured

Substances

  • Blood Glucose
  • DNM1L protein, human
  • Dynamins
  • Glucose